Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine

Hoelen, Dianne W.M., Spiering, Wilko, Valk, Gerlof D. · 2009 · New England Journal of Medicine

AI-extracted · unverified · confirm at source

Ibogaine-induced Long-QT syndrome (QTc 616 ms) with ventricular tachyarrhythmias in a 31-year-old woman; QT normalised at 42 hours; concurrent hypomagnesaemia and hypokalaemia identified.

Dosing: 3.5 g ibogaine 15% preparation (single dose) (not-specified)

Sample size: 1

Safety data present: QTC, ELECTROLYTE

Contraindications: Pre-existing QT prolongation, Electrolyte imbalance (hypomagnesaemia, hypokalaemia)